432 filings
Page 5 of 22
POS EX
7yboj
2 Nov 11
Additional exhibits for listing
12:00am
424B5
ziotb
2 Nov 11
Prospectus supplement for primary offering
12:00am
FWP
50qeyyfdn4fe75uxh
2 Nov 11
Free writing prospectus
12:00am
8-K
db5t g6e3gyd59gh
25 Oct 11
Human Genome Sciences Announces Third Quarter 2011 Financial Results and Key Developments
12:00am
8-K
hh94ga0hvs9yhtt61ke
30 Sep 11
NICE draft guidance denies funding for lupus treatment Benlysta on the NHS
12:00am
8-K
5l89xpb
8 Sep 11
Regulation FD Disclosure
12:00am
UPLOAD
oakn3b1 1ouj
16 Aug 11
Letter from SEC
12:00am
8-K
h2f di5vmv55z7f
1 Aug 11
Unregistered Sales of Equity Securities
12:00am
S-8
cvkrx3cswv avxuq
28 Jul 11
Registration of securities for employees
12:00am
8-K
1q2nn
21 Jul 11
Human Genome Sciences Announces Second Quarter 2011 Financial Results and Key Developments
12:00am
CORRESP
t6ihvmkerjvsj43 hpo
20 Jul 11
Correspondence with SEC
12:00am
8-K
7nme721ud3rfyee4
14 Jul 11
Other Events
12:00am
UPLOAD
29or wun5wf2wmnzsh
7 Jul 11
Letter from SEC
12:00am
CORRESP
lpnzlug
8 Jun 11
Correspondence with SEC
12:00am
CORRESP
7vrkxj 6sv4s1lx3
26 May 11
Correspondence with SEC
12:00am
CORRESP
b57k3ft 5o
19 May 11
Correspondence with SEC
12:00am
8-K/A
anfwgobvo 5s7jki8d0
12 May 11
Departure of Directors or Certain Officers
12:00am
UPLOAD
ipv5i5
12 May 11
Letter from SEC
12:00am